Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Alzheimer's Disease

  Free Subscription

Articles published in Neuroreport

Retrieve available abstracts of 29 articles:
HTML format

Single Articles

    July 2021
  1. HE F, Li Y, Li C, Zhao J, et al
    Changes in the connection network of whole-brain fiber tracts in patients with Alzheimer's disease have a tendency of lateralization.
    Neuroreport. 2021 Jul 30. pii: 00001756-900000000-97782.
    PubMed     Abstract available

    May 2021
  2. YANG H, Zhang J, Cheng J
    Effects of donepezil on the amplitude of low-frequency fluctuations in the brain of patients with Alzheimer's disease: evidence from resting-state functional magnetic resonance imaging.
    Neuroreport. 2021 May 20. pii: 00001756-900000000-97821.
    PubMed     Abstract available

  3. ZHOU X, Zhang Y, Jiang Y, Zhou C, et al
    Poria cocos polysaccharide attenuates damage of nervus in Alzheimer's disease rat model induced by D-galactose and aluminum trichloride.
    Neuroreport. 2021;32:727-737.
    PubMed     Abstract available

    January 2021
  4. LEI S, Wu S, Wang G, Li B, et al
    Pinoresinol diglucoside attenuates neuroinflammation, apoptosis and oxidative stress in a mice model with Alzheimer's disease.
    Neuroreport. 2021 Jan 18. pii: 00001756-900000000-97875.
    PubMed     Abstract available

    September 2020
  5. YANG Y, Hu S, Lin H, He J, et al
    Electroacupuncture at GV24 and bilateral GB13 improves cognitive ability via influences the levels of Abeta, p-tau (s396) and p-tau (s404) in the hippocampus of Alzheimer's disease model rats.
    Neuroreport. 2020 Sep 4. doi: 10.1097/WNR.0000000000001518.
    PubMed     Abstract available

    July 2020
  6. LIU M, Qian T, Zhou W, Tao X, et al
    Beneficial effects of low-dose lithium on cognitive ability and pathological alteration of Alzheimer's disease transgenic mice model.
    Neuroreport. 2020 Jul 3. doi: 10.1097/WNR.0000000000001499.
    PubMed     Abstract available

    February 2020
  7. ZHANG N, Li WW, Lv CM, Gao YW, et al
    miR-16-5p and miR-19b-3p prevent amyloid beta-induced injury by targeting BACE1 in SH-SY5Y cells.
    Neuroreport. 2020;31:205-212.
    PubMed     Abstract available

    November 2019
  8. FAN C, Huang X, Song H, Jia J, et al
    Presenilin 1 intronic polymorphism in sporadic Alzheimer's disease in a Northern Chinese population.
    Neuroreport. 2019 Nov 22. doi: 10.1097/WNR.0000000000001363.
    PubMed     Abstract available

  9. XIAO X, Wei J, Zhang W, Jiao B, et al
    TOMM40 polymorphism is associated with resting-state functional MRI results in patients with Alzheimer's disease.
    Neuroreport. 2019;30:1068-1073.
    PubMed     Abstract available

    June 2019
  10. ZHANG J, Tang C, Liao W, Zhu M, et al
    The antiapoptotic and antioxidative stress effects of Zhisanzhen in the Alzheimer's disease model rat.
    Neuroreport. 2019;30:628-636.
    PubMed     Abstract available

    May 2019
  11. PARK HJ, Jang JK, Choi YM, Choi WS, et al
    JBPOS0101 attenuates amyloid-beta accumulation and memory loss in a mouse model of Alzheimer's disease.
    Neuroreport. 2019 May 14. doi: 10.1097/WNR.0000000000001269.
    PubMed     Abstract available

  12. ZHANG J, Tang C, Liao W, Zhu M, et al
    The antiapoptotic and antioxidative stress effects of Zhisanzhen in the Alzheimer's disease model rat.
    Neuroreport. 2019 May 14. doi: 10.1097/WNR.0000000000001243.
    PubMed     Abstract available

  13. ZHANG XL, Zhao N, Xu B, Chen XH, et al
    Treadmill exercise inhibits amyloid-beta generation in the hippocampus of APP/PS1 transgenic mice by reducing cholesterol-mediated lipid raft formation.
    Neuroreport. 2019;30:498-503.
    PubMed     Abstract available

    December 2018
  14. SONG C, Li M, Xu L, Shen Y, et al
    Mitochondrial biogenesis mediated by melatonin in an APPswe/PS1dE9 transgenic mice model.
    Neuroreport. 2018;29:1517-1524.
    PubMed     Abstract available

    September 2018
  15. HESHMATI-FAKHR N, Sotoodehnejadnematalahi F, Yousefi N, Sayyah M, et al
    Triggering microglia through toll-like receptor 2 pathway induced interferon beta expression in cell and animal model of Alzheimer's disease.
    Neuroreport. 2018 Sep 14. doi: 10.1097/WNR.0000000000001132.
    PubMed     Abstract available

    August 2018
  16. ZHONG Z, Yuan K, Tong X, Hu J, et al
    MiR-16 attenuates beta-amyloid-induced neurotoxicity through targeting beta-site amyloid precursor protein-cleaving enzyme 1 in an Alzheimer's disease cell model.
    Neuroreport. 2018 Aug 23. doi: 10.1097/WNR.0000000000001118.
    PubMed     Abstract available

    July 2018
  17. MACHADO AE, de Sousa G, Mancini G, Faria MS, et al
    Hypercholesterolemia impairs contextual fear conditioning memory formation in female mice: evidence for cholinergic dysfunction.
    Neuroreport. 2018 Jul 9. doi: 10.1097/WNR.0000000000001091.
    PubMed     Abstract available

  18. ZHAO N, Zhang X, Song C, Yang Y, et al
    The effects of treadmill exercise on autophagy in hippocampus of APP/PS1 transgenic mice.
    Neuroreport. 2018;29:819-825.
    PubMed     Abstract available

  19. JIAO C, Gao F, Ou L, Yu J, et al
    Tetrahydroxystilbene glycoside antagonizes beta-amyloid-induced inflammatory injury in microglia cells by regulating PU.1 expression.
    Neuroreport. 2018;29:787-793.
    PubMed     Abstract available

  20. LI H, Zheng L, Jiang A, Mo Y, et al
    Identification of the biological affection of long noncoding RNA BC200 in Alzheimer's disease.
    Neuroreport. 2018 Jul 3. doi: 10.1097/WNR.0000000000001057.
    PubMed     Abstract available

    June 2018
  21. HODGES SL, Reynolds CD, Smith GD, Jefferson TS, et al
    Molecular interplay between hyperactive mammalian target of rapamycin signaling and Alzheimer's disease neuropathology in the NS-Pten knockout mouse model.
    Neuroreport. 2018 Jun 29. doi: 10.1097/WNR.0000000000001081.
    PubMed     Abstract available

    May 2018
  22. SHANG YY, Ma YJ, Zhang L, Wang LJ, et al
    Flavonoids extracted from leaves of Diospyros kaki regulates RhoA activity to rescue synapse loss and reverse memory impairment in APP/PS1 mice.
    Neuroreport. 2018;29:564-569.
    PubMed     Abstract available

    February 2018
  23. OH M, Seo M, Oh SY, Kim H, et al
    Clinical significance of visually equivocal amyloid PET findings from the Alzheimer's Disease Neuroimaging Initiative cohort.
    Neuroreport. 2018 Feb 12. doi: 10.1097/WNR.0000000000000986.
    PubMed     Abstract available

    January 2018
  24. DONG H, Wu S, Hu N, Xing G, et al
    Efficacy of tenuigenin and beta-asarone as augmentations for memantine in the treatment of Alzheimer's disease.
    Neuroreport. 2018 Jan 2. doi: 10.1097/WNR.0000000000000952.
    PubMed     Abstract available

    December 2017
  25. XUE SW, Guo Y
    Increased resting-state brain entropy in Alzheimer's disease.
    Neuroreport. 2017 Dec 12. doi: 10.1097/WNR.0000000000000942.
    PubMed     Abstract available

    September 2017
  26. THOMAS RS, Alsaqati M, Bice JS, Hvoslef-Eide M, et al
    Alterations in endocytic protein expression with increasing age in the transgenic APP695 V717I London mouse model of amyloid pathology: implications for Alzheimer's disease.
    Neuroreport. 2017 Sep 6. doi: 10.1097/WNR.0000000000000861.
    PubMed     Abstract available

    May 2017
  27. GUO Y, Zhao Y, Nan Y, Wang X, et al
    (-)-Epigallocatechin-3-gallate ameliorates memory impairment and rescues the abnormal synaptic protein levels in the frontal cortex and hippocampus in a mouse model of Alzheimer's disease.
    Neuroreport. 2017 May 17. doi: 10.1097/WNR.0000000000000803.
    PubMed     Abstract available

    January 2017
  28. XU LL, Shen Y, Wang X, Wei LF, et al
    Mitochondrial dynamics changes with age in an APPsw/PS1dE9 mouse model of Alzheimer's disease.
    Neuroreport. 2017 Jan 21. doi: 10.1097/WNR.0000000000000739.
    PubMed     Abstract available

    November 2016
  29. JANG S, Lee JH, Sohn BK, Kim E, et al
    Suppression of AIMP1 protects cognition in Alzheimer's disease model mice 3xTg-AD.
    Neuroreport. 2016.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.